BiotechTube

Full Dose Strength + Quarter dose strength + Half dose strength + Acetaminophen standard dose + Ibuprofen low dose + Ibuprofen high dose + Placebo

Phase 2Withdrawn
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dental Pain

Conditions

Dental Pain

Trial Timeline

— → —

NCT ID
NCT01104844

About Full Dose Strength + Quarter dose strength + Half dose strength + Acetaminophen standard dose + Ibuprofen low dose + Ibuprofen high dose + Placebo

Full Dose Strength + Quarter dose strength + Half dose strength + Acetaminophen standard dose + Ibuprofen low dose + Ibuprofen high dose + Placebo is a phase 2 stage product being developed by AFT Pharmaceuticals for Dental Pain. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01104844. Target conditions include Dental Pain.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01104844Phase 2Withdrawn

Competing Products

20 competing products in Dental Pain

See all competitors
ProductCompanyStageHype Score
Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tabletJohnson & JohnsonPhase 3
77
Sodium Fluoride DentifriceJohnson & JohnsonPre-clinical
23
Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
77
Acetaminophen (ACE) (1000 mg) + Commercial ACE (1000 mg) + Commercial Ibuprofen (IBU) (400 mg) + Placebo + Placebo + PlaceboJohnson & JohnsonPhase 2
52
2 mg nicotine gum + 4 mg nicotine gumJohnson & JohnsonApproved
85
Acetaminophen ER + PlaceboJohnson & JohnsonPhase 2
52
acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsuleJohnson & JohnsonPhase 3
77
Diclofenac potassium + Ibuprofen + Placebo to ibuprofen + Placebo to diclofenac potassiumNovartisPhase 3
77
Placebo; oral + Placebo; oral + ARRY-371797, p38 inhibitor; oral + ARRY-371797, p38 inhibitor; oral + Celecoxib, COX-2 inhibitor; oral + Placebo; oral + ARRY-371797, p38 inhibitor; oralPfizerPhase 2
51
Pregabalin + Alprazolam + PlaceboPfizerPhase 2
51
Prototype (AN0128 Toothpaste)PfizerPhase 1
32
PF-05089771 + PF-05089771 + PF-05089771 + IbuprofenPfizerPhase 2
51
ARRY-371797, p38 inhibitor; oral + Placebo; oral + Placebo; oral + ARRY-371797, p38 inhibitor; oralPfizerPhase 2
51
PF-04531083 + PF-04531083 + IbuprofenPfizerPhase 2
51
Naproxen sodium and caffeine (BAY2880376) + Naproxen sodium (Aleve) + Caffeine + PlaceboBayerPhase 3
74
XPF-001 + placeboXenon PharmaceuticalsPhase 2
49
N1539 + placebo + N1539 + N1539 + MotrinAlkermesPhase 2
49
Comparator: etoricoxib + Comparator: ibuprofen + Comparator: acetaminophen + codeine + Comparator: placeboOrganonPhase 3
72
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboAFT PharmaceuticalsPhase 3
69
C16G2 GelArmata PharmaceuticalsPhase 2
44

Other Products from AFT Pharmaceuticals

Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)Phase 3
69
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IVPhase 3
69
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboPhase 3
69
Maxigesic® IVPhase 3
69
Acetaminophen + Maxigesic 325 + Ibuprofen + PlaceboPhase 3
69